• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴丝虫病患者的临床特征与群体服药覆盖率:一项描述性研究。

Clinical profile and Mass Drug Administration coverage in patients with lymphatic filariasis: A descriptive study.

作者信息

Pareek Sumit, Ranjan Nishit, Patidar Vipin, Mudgal Shiv Kumar, Gupta Pratima

机构信息

MBBS Students, All India Institute of Medical Sciences, Deoghar, Jharkhand, India.

Department of General Surgery, All India Institute of Medical Sciences, Deoghar, Jharkhand, India.

出版信息

J Family Med Prim Care. 2025 Jul;14(7):2902-2907. doi: 10.4103/jfmpc.jfmpc_2056_24. Epub 2025 Jul 21.

DOI:10.4103/jfmpc.jfmpc_2056_24
PMID:40814541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12349841/
Abstract

BACKGROUND AND AIMS

Lymphatic filariasis (LF), a tropical illness caused by mosquito-borne parasites, is a serious public health concern in endemic areas such as Jharkhand, India. The illness continues despite efforts by the World Health Organization and the Mass Drug Administration (MDA). This study aims to investigates the clinical and demographic profiles of patients with LF and assesses coverage of MDA.

METHODS

This cross-sectional study included 100 patients with LF who presented to the General Surgery Outpatient Department. Interviews, clinical exams, and semi-structured questionnaires were used to obtain information about sociodemographic profile, clinical symptoms and MDA coverage. Descriptive statistics and Chi-square tests were used to find the association between clinical profile, drug consumption, and sociodemographic profiles.

RESULTS

The study revealed that participants were mostly middle-aged, married (55%), from low-income families (86%), and had varied degrees of hydrocele and lymphedema, with nearly 70% experiencing scrotal enlargement. Furthermore, 44% of patients reported insufficient MDA coverage. There were significant connections found between the size of the hydrocele ( < 0.01) and actual drug consumption ( < 0.01) with socioeconomic status.

CONCLUSIONS

The study highlights important clinical, sociodemographic patterns, and reveal MDA coverage gaps among patients with LF. There is a need of targeted education and enhanced treatment access to improve MDA effectiveness and achieving LF eradication by 2030.

摘要

背景与目的

淋巴丝虫病(LF)是一种由蚊媒寄生虫引起的热带疾病,在印度贾坎德邦等流行地区是严重的公共卫生问题。尽管世界卫生组织和大规模药物管理(MDA)做出了努力,但这种疾病仍在持续。本研究旨在调查LF患者的临床和人口统计学特征,并评估MDA的覆盖情况。

方法

这项横断面研究纳入了100名到普通外科门诊就诊的LF患者。通过访谈、临床检查和半结构化问卷来获取有关社会人口统计学特征、临床症状和MDA覆盖情况的信息。使用描述性统计和卡方检验来找出临床特征、药物消费和社会人口统计学特征之间的关联。

结果

研究显示,参与者大多为中年、已婚(55%)、来自低收入家庭(86%),并有不同程度的鞘膜积液和淋巴水肿,近70%的人阴囊肿大。此外,44%的患者报告MDA覆盖不足。鞘膜积液大小(<0.01)和实际药物消费(<0.01)与社会经济地位之间存在显著关联。

结论

该研究突出了重要的临床、社会人口统计学模式,并揭示了LF患者中MDA覆盖的差距。需要有针对性的教育并增加治疗机会,以提高MDA的有效性并在2030年实现LF的消除。

相似文献

1
Clinical profile and Mass Drug Administration coverage in patients with lymphatic filariasis: A descriptive study.淋巴丝虫病患者的临床特征与群体服药覆盖率:一项描述性研究。
J Family Med Prim Care. 2025 Jul;14(7):2902-2907. doi: 10.4103/jfmpc.jfmpc_2056_24. Epub 2025 Jul 21.
2
Community views on mass drug administration for soil-transmitted helminths: a qualitative evidence synthesis.社区对土壤传播蠕虫群体药物给药的看法:定性证据综合分析
Cochrane Database Syst Rev. 2025 Jun 20;6:CD015794. doi: 10.1002/14651858.CD015794.pub2.
3
Epidemiological monitoring survey to assess the impact of mass drug administration with triple-drug regimen in lymphatic filariasis elimination programme in an endemic district in Southern India.在印度南部一个流行地区开展的一项流行病学监测调查,以评估采用三联药物疗法进行群体服药在淋巴丝虫病消除计划中的影响。
PLoS Negl Trop Dis. 2025 Aug 1;19(8):e0013368. doi: 10.1371/journal.pntd.0013368. eCollection 2025 Aug.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Community views on mass drug administration for filariasis: a qualitative evidence synthesis.社区对丝虫病大规模药物治疗的看法:定性证据综合分析。
Cochrane Database Syst Rev. 2022 Feb 17;2(2):CD013638. doi: 10.1002/14651858.CD013638.pub2.
6
Acceptability of mass drug administration for lymphatic filariasis in Baglung Municipality of Nepal: A mixed-method study.尼泊尔巴隆市大规模药物治疗淋巴丝虫病的可接受性:一项混合方法研究。
PLOS Glob Public Health. 2025 Jul 21;5(7):e0004910. doi: 10.1371/journal.pgph.0004910. eCollection 2025.
7
Evaluation of sampling strategies for assessing lymphatic filariasis endemic status of a non-MDA district in South India.印度南部一个非大规模药物治疗地区淋巴丝虫病流行状况评估的抽样策略研究
PLoS Negl Trop Dis. 2025 Jun 25;19(6):e0013192. doi: 10.1371/journal.pntd.0013192. eCollection 2025 Jun.
8
Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trial.重复使用伊维菌素进行疟疾控制的安全性和有效性(RIMDAMAL II):一项3期、双盲、安慰剂对照、整群随机、平行组试验。
Lancet Infect Dis. 2025 Jul;25(7):737-750. doi: 10.1016/S1473-3099(24)00751-5. Epub 2025 Feb 4.
9
Investigation and analysis of mental health status of the older adult in western rural areas.西部农村地区老年人心理健康状况的调查与分析
Front Public Health. 2025 Jul 16;13:1612600. doi: 10.3389/fpubh.2025.1612600. eCollection 2025.
10
Examining the overlap in lymphatic filariasis prevalence and malaria insecticide-treated net access-use in endemic Africa.研究非洲流行地区淋巴丝虫病患病率与疟疾杀虫剂处理蚊帐的使用情况之间的重叠情况。
PLoS Negl Trop Dis. 2025 Jun 26;19(6):e0013165. doi: 10.1371/journal.pntd.0013165. eCollection 2025 Jun.

本文引用的文献

1
Factors influencing implementation of mass drug administration for lymphatic filariasis elimination: a mixed-method study in Odisha, India.影响消除淋巴丝虫病群体服药实施的因素:印度奥里萨邦的一项混合方法研究
Front Pharmacol. 2024 Feb 13;15:1297954. doi: 10.3389/fphar.2024.1297954. eCollection 2024.
2
Socio-economic and environmental factors associated with high lymphatic filariasis morbidity prevalence distribution in Bangladesh.与孟加拉国高淋巴丝虫病发病率分布相关的社会经济和环境因素。
PLoS Negl Trop Dis. 2023 Jul 11;17(7):e0011457. doi: 10.1371/journal.pntd.0011457. eCollection 2023 Jul.
3
Coverage of mass drug administration (MDA) and operational issues in elimination of lymphatic filariasis in selected districts of Jharkhand, India.
印度恰尔肯德邦部分地区大规模药物给药(MDA)的覆盖情况及消除淋巴丝虫病的操作问题
J Family Med Prim Care. 2023 Jan;12(1):111-116. doi: 10.4103/jfmpc.jfmpc_1149_22. Epub 2023 Feb 15.
4
Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review.与大规模药物治疗丝虫病可接受性相关的因素:系统评价。
Int J Environ Res Public Health. 2022 Oct 10;19(19):12971. doi: 10.3390/ijerph191912971.
5
Mass drug administration for lymphatic filariasis elimination amidst COVID-19 pandemic in Odisha, India: A step towards achieving SDG-3.在印度奥里萨邦 COVID-19 大流行期间消除淋巴丝虫病的大规模药物治疗:迈向实现可持续发展目标 3 的一步。
Trop Doct. 2022 Oct;52(4):556-559. doi: 10.1177/00494755221098532. Epub 2022 Jun 30.
6
Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned.印度加速消除淋巴丝虫病的三联药物疗法介绍:经验教训
Am J Trop Med Hyg. 2022 Mar 15;106(5_Suppl):29-38. doi: 10.4269/ajtmh.21-0964. Print 2022 May 11.
7
Disease Burden Estimation of Lymphatic Filariasis in an Endemic Area.淋巴丝虫病流行区疾病负担估计。
Lymphat Res Biol. 2022 Jun;20(3):319-324. doi: 10.1089/lrb.2020.0014. Epub 2021 Oct 6.
8
Lifestyle behavior of budding health care professionals: A cross-sectional descriptive study.初出茅庐的医疗保健专业人员的生活方式行为:一项横断面描述性研究。
J Family Med Prim Care. 2020 Jul 30;9(7):3525-3531. doi: 10.4103/jfmpc.jfmpc_491_20. eCollection 2020 Jul.
9
Socioeconomic Status and Access to Healthcare: Interrelated Drivers for Healthy Aging.社会经济地位与医疗保健获取:健康老龄化的相互关联驱动因素。
Front Public Health. 2020 Jun 18;8:231. doi: 10.3389/fpubh.2020.00231. eCollection 2020.
10
Lymphedema Impact and Prevalence International Study: The Canadian Data.淋巴水肿影响与患病率国际研究:加拿大数据。
Lymphat Res Biol. 2019 Apr;17(2):178-186. doi: 10.1089/lrb.2019.0014.